Literature DB >> 10845969

Use of statins in general practices, 1996-8: cross sectional study.

C Packham1, J Pearson, J Robinson, D Gray.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10845969      PMCID： PMC27405          DOI： 10.1136/bmj.320.7249.1583

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Time trend analysis and variations in prescribing lipid lowering drugs in general practice.

Authors:  C Baxter; R Jones; L Corr
Journal:  BMJ       Date:  1998-10-24

2.  Statin prescribing in Nottingham general practices: a cross-sectional study.

Authors:  C Packham; J Robinson; J Morris; C Richards; P Marks; D Gray
Journal:  J Public Health Med       Date:  1999-03

3.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321
  3 in total
  17 in total

1.  Discontinuation rates for use of statins are high.

Authors:  L A Simons; J Simons; P McManus; J Dudley
Journal:  BMJ       Date:  2000-10-28

2.  Evidence for inequalities in the management of coronary heart disease in Scotland.

Authors:  C R Simpson; P C Hannaford; D Williams
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

3.  Use of lipid-lowering drugs during 1991-98 in Northern Jutland, Denmark.

Authors:  S Riahi; K Fonager; E Toft; L Hvilsted-Rasmussen; J Bendsen; S Paaske Johnsen; H T Sørensen
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

4.  Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?

Authors:  Aukje K Mantel-Teeuwisse; Olaf H Klungel; W M Monique Verschuren; Arijan J Porsius; Anthonius de Boer
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

5.  Statin-associated weakness in myasthenia gravis: a case report.

Authors:  Michael J Keogh; John M Findlay; Simon Leach; John Bowen
Journal:  J Med Case Rep       Date:  2010-02-20

6.  Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.

Authors:  P R Ward; P R Noyce; A S St Leger
Journal:  J Epidemiol Community Health       Date:  2004-02       Impact factor: 3.710

7.  Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.

Authors:  L Wei; J Wang; P Thompson; S Wong; A D Struthers; T M MacDonald
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

8.  Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation.

Authors:  Chen-Chang Yang; Susan S Jick; Marcia A Testa
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

9.  Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?

Authors:  S DeWilde; I M Carey; S A Bremner; N Richards; S R Hilton; D G Cook
Journal:  Heart       Date:  2003-04       Impact factor: 5.994

10.  Low prevalence of lipid lowering drug use in older men with established coronary heart disease.

Authors:  P H Whincup; J R Emberson; L Lennon; M Walker; O Papacosta; A Thomson
Journal:  Heart       Date:  2002-07       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.